Press Room http://www.news.sanofi.us/ MediaRoom Sanofi Announces Q2 2016 Results http://www.news.sanofi.us/2016-07-29-Sanofi-Announces-Q2-2016-Results Fri, 29 Jul 2016 08:00:00 -0400 http://www.news.sanofi.us/2016-07-29-Sanofi-Announces-Q2-2016-Results Sanofi Receives FDA Approval of Adlyxin™ for Treatment of Adults with Type 2 Diabetes http://www.news.sanofi.us/2016-07-27-Sanofi-Receives-FDA-Approval-of-AdlyxinTM-for-Treatment-of-Adults-with-Type-2-Diabetes - Adlyxin™ is approved as Lyxumia® in more than 60 countries - Wed, 27 Jul 2016 20:12:00 -0400 http://www.news.sanofi.us/2016-07-27-Sanofi-Receives-FDA-Approval-of-AdlyxinTM-for-Treatment-of-Adults-with-Type-2-Diabetes Surveys Find Adults with Type 2 Diabetes Are More Willing to Take Action to Achieve A1C Targets Quicker than Physicians and Other Medical Professionals Perceive http://www.news.sanofi.us/2016-07-20-Surveys-Find-Adults-with-Type-2-Diabetes-Are-More-Willing-to-Take-Action-to-Achieve-A1C-Targets-Quicker-than-Physicians-and-Other-Medical-Professionals-Perceive -- Findings reveal that some patients are frustrated and discontinued medication because they were not reaching their individualized A1C target quick enough -- Wed, 20 Jul 2016 09:05:00 -0400 http://www.news.sanofi.us/2016-07-20-Surveys-Find-Adults-with-Type-2-Diabetes-Are-More-Willing-to-Take-Action-to-Achieve-A1C-Targets-Quicker-than-Physicians-and-Other-Medical-Professionals-Perceive Award-Winning Chef Elizabeth Falkner Reveals Her Struggle with Atopic Dermatitis to Highlight the Physical and Psychological Impact of the Disease http://www.news.sanofi.us/2016-07-12-Award-Winning-Chef-Elizabeth-Falkner-Reveals-Her-Struggle-with-Atopic-Dermatitis-to-Highlight-the-Physical-and-Psychological-Impact-of-the-Disease Falkner has joined forces with Regeneron and Sanofi Genzyme in collaboration with leading dermatology organizations to educate Americans about a potentially serious, chronic inflammatory skin disease known as atopic dermatitis. Tue, 12 Jul 2016 07:00:00 -0400 http://www.news.sanofi.us/2016-07-12-Award-Winning-Chef-Elizabeth-Falkner-Reveals-Her-Struggle-with-Atopic-Dermatitis-to-Highlight-the-Physical-and-Psychological-Impact-of-the-Disease Sanofi Announces Positive Phase 3 Results for Investigational Titratable Fixed-Ratio Combination of Insulin Glargine and Lixisenatide http://www.news.sanofi.us/2016-06-12-Sanofi-Announces-Positive-Phase-3-Results-for-Investigational-Titratable-Fixed-Ratio-Combination-of-Insulin-Glargine-and-Lixisenatide - Both pivotal studies demonstrated superior reduction in HbA1c versus insulin glargine and versus lixisenatide - Sun, 12 Jun 2016 15:54:00 -0400 http://www.news.sanofi.us/2016-06-12-Sanofi-Announces-Positive-Phase-3-Results-for-Investigational-Titratable-Fixed-Ratio-Combination-of-Insulin-Glargine-and-Lixisenatide